High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
about
Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursingRelevant prognostic features of multiple myeloma and the new International Staging System.Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.
P2860
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
High-dose chemotherapy with au ...... atients with multiple myeloma.
@ast
High-dose chemotherapy with au ...... atients with multiple myeloma.
@en
type
label
High-dose chemotherapy with au ...... atients with multiple myeloma.
@ast
High-dose chemotherapy with au ...... atients with multiple myeloma.
@en
prefLabel
High-dose chemotherapy with au ...... atients with multiple myeloma.
@ast
High-dose chemotherapy with au ...... atients with multiple myeloma.
@en
P2860
P50
P356
P1476
High-dose chemotherapy with au ...... atients with multiple myeloma.
@en
P2093
Shaji K Kumar
P2860
P304
P356
10.1586/14737140.6.3.343
P577
2006-03-01T00:00:00Z